http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101007541-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
filingDate 2008-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2011-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2011-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101007541-B1
titleOfInvention Pharmaceutical composition for the treatment of liver disease
abstract The present invention relates to a pharmaceutical composition for inhibiting the development of liver disease by detoxifying various harmful substances that adversely affect the liver of the human body, and more particularly, comprising a jinjin extract, barberry extract and a pharmaceutically acceptable carrier. It is possible to protect the liver by reducing the activity of the harmful substances by effectively inhibiting the transfer of various harmful substances adversely affecting the liver to free radicals by the synergistic action of the extracts of jinjin and Bran lotus, which are active ingredients. It provides a pharmaceutical composition for treating liver disease.n n n n Phosphorus, Bacterium, Liver Disease, Pharmaceutical, Free Group, Mixed Composition
priorityDate 2008-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-19990046401-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4550
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4432
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31553
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID63417
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486168
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4432
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10964
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID51240
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID63417
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4550
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID85223
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID85223
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24404
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID5315
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID309271
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID309271
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723628
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID5315
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550161
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4220
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID265783
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4220
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID265783
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID51240
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161524029
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453649322

Total number of triples: 44.